Coronavirus COVID-19 - Theoretical and Practical Substantiations for Reducing Mortality from Complications

Abstract


The high mortality rate and the enormous socio-economic consequences of the COVID-19 virus epidemic require the immediate
development of effective treatment methods. The main complication of coronavirus infection, leading to the development of a fatal
outcome, is pneumonia, respiratory and multiple organ failure, which develop in some patients with COVID-19 infection.

An analysis of the clinical, laboratory, and pathoanatomical picture of COVID-19 virus damage according to the literature suggests
that there is a presence in the pathogenesis of patients with chronic disseminated intravascular coagulation (chronic DIC) and intraalveolar fibrinogenesis.

Prevention of these processes, early therapy using the systemic method of leech therapy (SMP) of hirudotherapy, which has
about 30 types of therapeutic effects, including anticoagulant and thrombolytic effects, can prevent the development of severe, lifethreatening complications.

Keywords: COVID-19; Microthromboses; Systemic Method of Leech Therapy (SMP); Hirudotherapy

You can find a full version of the article in the attached *pdf file below.